Clinical Trial News Archive - March 2023
March 1, 2023
- Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
- US FDA Advisory Committee Votes to Support Effectiveness and Safety of GSK’s Respiratory Syncytial Virus older Adult Vaccine Candidate
- First Patient Dosed in Phase 3 Trial of Ecopipam for Tourette Syndrome
March 2, 2023
March 5, 2023
March 6, 2023
- Merck’s MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study
- Merck’s Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy
- Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
- Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis
March 7, 2023
March 8, 2023
- SpringWorks Therapeutics Announces New England Journal of Medicine Publication of Phase 3 DeFi Trial Evaluating Nirogacestat in Adults with Desmoid Tumors
- Lilly Provides Update on A4 Study of Solanezumab for Preclinical Alzheimer's Disease
- Researchers announce highly accurate blood test for Alzheimer's Disease
March 13, 2023
- Scientists Reveal a Potential New Approach to Treating Liver Cancer
- Results from Astellas' Pivotal Phase 3 SKYLIGHT 1™ Study of Fezolinetant for Vasomotor Symptoms Due to Menopause Published in The Lancet
- Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide
- Gene therapy candidate for amyotrophic lateral sclerosis (ALS) demonstrates bioactivities in a murine model of the disease
March 14, 2023
- GSK Announces Positive Pivotal Phase III Data for 5-in-1 Meningococcal ABCWY Vaccine Candidate
- Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years
March 15, 2023
- Positive results from a pharmacokinetic study with cobitolimod in patients with moderate to severe ulcerative colitis
- Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature
March 16, 2023
March 17, 2023
- Merck Provides Update from Open-Label Arm of Phase 2 KeyVibe-002 Trial Evaluating MK-7684A, a Coformulation of Vibostolimab and Pembrolizumab, in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Phase 3 Study Shows XTANDI plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer
March 20, 2023
- Patritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials
- First Subjects Dosed in Phase 1 Clinical Trial of VXX-401, Investigational Anti-PCSK9 Vaccine to Treat Hypercholesterolemia
March 21, 2023
- Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
- New Yale study evaluates PAXLOVID's use in Long COVID recovery
- Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham
- Altimmune Announces Positive Results From Week 24 Interim Analysis Of Pemvidutide MOMENTUM Phase 2 Obesity Trial And 12-Week Phase 1b Type 2 Diabetes Safety Trial
March 22, 2023
March 23, 2023
March 24, 2023
March 27, 2023
- Eplontersen Demonstrated Sustained Benefit in Phase III Trial for Hereditary Transthyretin-Mediated Amyloid Polyneuropathy (ATTRv-PN) Through 66 Weeks
- HIV Can Persist for Years in Myeloid Cells of People on Antiretroviral Therapy
- Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease
March 28, 2023
- Trial Results for Ovarian Cancer will lead to new Standard of Care
- NIH Researchers Discover New Autoinflammatory Disease, Suggest Target for Potential Treatments
- Regeneron and Sonoma Biotherapeutics Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
March 29, 2023
March 30, 2023
Clinical trial results archive
- 2025
- January, February, March, April, May
- 2024
- January, February, March, April, May, June, July, August, September, October, November, December
- 2023
- January, February, March, April, May, June, July, August, September, October, November, December
- 2022
- January, February, March, April, May, June, July, August, September, October, November, December
- 2021
- January, February, March, April, May, June, July, August, September, October, November, December
- 2020
- January, February, March, April, May, June, July, August, September, October, November, December
- 2019
- January, February, March, April, May, June, July, August, September, October, November, December
- 2018
- January, February, March, April, May, June, July, August, September, October, November, December
- 2017
- May, June, July, August, September, October, November, December
- 2016
- October
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.